Glaucoma Stem Cell 2020

Retinal ganglion cell rgc apoptosis and optic nerve damage are the main pathological changes.

Glaucoma stem cell 2020. Using human stem cell models researchers at indiana university school of medicine found they could analyze deficits within cells damaged by glaucoma with the potential to use this information to develop new strategies to slow the disease process. Indianapolis more than 3 million americans have glaucoma a serious eye condition causing vision loss. Glaucoma physician september 2020 issue. Patients with glaucoma should only consider receiving stem cell treatment in the context of a well regulated clinical trial after consultation with their personal ophthalmologist.

However there are currently no fda approved stem cell treatments for glaucoma. Using human stem cell models researchers at indiana university school of medicine found they could. Using human stem cell models researchers at indiana university school of medicine found they could analyze deficits within cells damaged by glaucoma with the potential to use this information to develop new strategies to slow the disease process. Hsin ya yang et al combination product of dermal matrix human mesenchymal stem cells and timolol promotes diabetic wound healing in mice stem cells translational medicine 2020.

Unfortunately current treatments for glaucom. Glaucoma is a neurodegenerative disease as a leading cause of global blindness. There is a great deal of hope and enthusiasm for the role of stem cells in the future treatment of glaucoma that is firmly supported by groundbreaking strong. Patients have elevated intraocular pressure and progressive visual field loss.